Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities: A Randomized Placebo-Controlled Double-Blind Clinical Trial

NCT05005052 is registered in ClinicalTrials.gov with Value Outcomes Ltd. as lead sponsor.

NCT NCT05005052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities: A Randomized Placebo-Controlled Double-Blind Clinical Trial
Lead sponsor
Value Outcomes Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
November 25, 2021
Completion date
December 31, 2023
Enrollment
290 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

chronic insufficiency venous, chronic venous disease